A2B adenosine receptor mediates human chorionic vasoconstriction and signals through arachidonic acid cascade

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 5 57-5, 2005, Pages

  Donoso, M Verónica ^a   López, Rodrigo ^a   Miranda, Ramiro ^a   Briones, René ^a   Huidobro Toro, J Pablo ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Adenosine induced vasoconstriction; Arachidonate metabolite; Human chorionic vessels; Placental vasculature; Thromboxane receptor antagonism

Indexed keywords

1 [2 CHLORO 6 [[(3 IODOPHENYL)METHYL]AMINO] 9H PURIN 9 YL] 1 DEOXY N METHYL BETA DEXTRO RIBOFURANONAMIDE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ARACHIDONIC ACID; CYCLOHEXYLADENOSINE; INDOMETACIN; POTASSIUM CHLORIDE; PROSTANOID; THROMBOXANE RECEPTOR BLOCKING AGENT; THROMBOXANE RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; VAPIPROST; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; MESSENGER RNA; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE; VASODILATOR AGENT; XANTHINE DERIVATIVE;

ARACHIDONIC ACID METABOLISM; ARTICLE; CHORION VILLUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; HUMAN; HUMAN TISSUE; MUSCLE ISOMETRIC CONTRACTION; PLACENTA CIRCULATION; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; VASOCONSTRICTION; VASOMOTOR REFLEX; CHORION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETICS; IN VITRO STUDY; METABOLISM; PHYSIOLOGY; PLACENTA; PREGNANCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ARACHIDONIC ACID; CHORION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; PLACENTA; PREGNANCY; RECEPTOR, ADENOSINE A2B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRIAZINES; TRIAZOLES; VASOCONSTRICTION; VASODILATOR AGENTS; XANTHINES;

EID: 18044370690     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00548.2004     Document Type: Article

References (56)

1. Adamson SL, Morrow RJ, Bull SB, and Langille BL. Vasomotor responses of the umbilical circulation in fetal sheep. Am J Physiol Regul Integr Comp Physiol 256: R1056-R1062, 1989.
2. Arens YH, Rosenfeld CR, and Kamm KE. Maturational differences between vascular and bladder smooth muscle during ovine development. Am J Physiol Regul Integr Comp Physiol 278: R1305-R1313, 2000.
3. Boersma JI, Janzen KM, Oliveira L, and Crankshaw DJ. Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro. Br J Pharmacol 128: 1505-1512, 1999.
4. 2 receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed. Br J Pharmacol 136: 847-856, 2002.
5. Chumczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
6. Cox BE and Rosenfeld CR. Ontogeny of vascular angiotensin II receptor subtype expression in ovine development. Pediatr Res 45: 414-424, 1999.
7. Cruz MA, Gallardo V, Miguel P, Carrasco G, and Gonzalez C. Serotonin-induced vasoconstriction is mediated by thromboxane release and action in the human fetal-placental circulation. Placenta 18: 197-204, 1997.
8. Cunha RA. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem Int 38: 107-125, 2001.
9. 2A receptors. Naunyn Schmiedebergs Arch Pharmacol 359: 295-302, 1999.
10. Dogné JM, de Leval X, Delarge J, David JL, and Masereel B. New trends in thromboxane and prostacyclin modulators. Curr Med Chem 7: 609-628, 2000.
11. Dunwiddie TV and Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24: 31-55, 2001.
12. 2B receptors. J Exp Med 198: 783-796, 2003.
13. 2α, 5-hydroxytryptamine, and potassium chloride. Res Exp Med (Berl) 195: 171-182, 1995.
14. Feoktistov I and Biaggioni I. Adenosine A2B receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96: 1979-1986, 1995.
15. 2B receptors. Pharmacol Rev 49: 381-402, 1997.
16. 2B angiogenic phenotype. Hypertension 44: 649-654, 2004.
17. 2B receptors from rat, guinea pig and dog. Eur J Pharmacol 475: 79-84, 2003.
18. Gharib A, Delton I, Lagarde M, and Sarda N. Evidence for adenosine A2b receptors in the rat pineal gland. Eur J Pharmacol 225: 359-360, 1992.
19. +-ATPase. Pharmacol Toxicol 92: 265-271, 2003.
20. Hinschen AK, Rose'Meyer RB, and Headrick JP. Adenosine receptor subtypes mediating coronary vasodilation in rat hearts. J Cardiovasc Pharmacol 41: 73-80, 2003.
21. Huidobro-Toro JP and Valdecantos P. Purinergic vasocontractile mechanisms in human chorionic vessels. J Physiol 523P: 102P-103P, 2000.
22. 2 receptor-cAMP system in human aortic endothelial cells. Biochem Biophys Res Commun 199: 905-910, 1994.
23. 2 adenosine receptor antagonists. Pure Appl Chem 73: 1411-1420, 2001.
24. 3 receptor subtype. J Med Chem 39: 4142-4148, 1996.
25. Kingdom JC, McQueen J, Connell JM, and Whittle MJ. Fetal angiotensin II levels and vascular (type 1) angiotensin receptors in pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynaecol 100: 476-482, 1993.
26. Klotz K. Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol 362: 382-391, 2000.
27. 3 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 360: 103-108, 1999.
28. Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, and Lohse MJ. Comparative pharmacology of human adenosine receptor subtypes- characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 357: 1-9, 1998.
29. 3 receptor agonists. Biochem Biophys Res Commun 219: 904-910, 1996.
30. 2A receptor. Nature 388: 674-678, 1997.
31. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41: 775-787, 2001.
32. q in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol 56: 705-713, 1999.
33. Lumley P, White BP, and Humphrey PPA. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Br J Pharmacol 97: 783-794, 1989.
34. Marquardt DL, Walker LL, and Heinemann S. Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. J Immunol 152: 4508-4515, 1994.
35. 1 adenosine receptors in normal and cystic fibrosis human airway epithelial cells. Am J Physiol Cell Physiol 268: C1520-C1527, 1995.
36. 1 receptor antagonists and the kidney. Curr Opin Nephrol Hypertens 12: 497-502, 2003.
37. Murthy KS, McHenry L, Grider JR, and Makhlouf GM. Adenosine A1 and A2b receptors coupled to distinct interactive signaling pathways in intestinal muscle cells. J Pharmacol Exp Ther 274: 300-306, 1995.
38. Nicholls J, Brownhill VR, and Hourani SM. Characterization of PI-purinoceptors on rat isolated duodenum longitudinal muscle and muscularis mucosae. Br J Pharmacol 117: 170-174, 1996.
39. Obata T. Adenosine production and its interaction with protection of ischemic and reperfusion injury of the myocardium. Life Sci 71: 2083-2103, 2002.
40. Parisi VM and Rankin JH. The effect of prostacyclin on angiotensin II-induced placental vasoconstriction. Am J Obstet Gynecol 151:444-449, 1985.
41. Parisi VM and Walsh SW. Arachidonic acid metabolites and the regulation of placental and other vascular tone during pregnancy. Semin Perinatol 10:288-298, 1986.
42. Patrignani P, Panara MR, Greco A, Fusco O, Natoli C, Iacobelli S, Cipollone F, Ganci A, Creminon C, and Maclouf J. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 271: 1705-1712, 1994.
43. 2A selective adenosine receptor antagonist. Br J Pharmacol 115: 1096-1102, 1995.
44. Racchi H, Irarrazabal MJ, Howard M, Moran S, Zalaquett R, and Huidobro-Toro JP. Adenosine 5′-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein. Br J Pharmacol 126: 1175-1785, 1999.
45. Ralevic V and Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50, 413-492, 1998.
46. Rankin JH and Phernetton TM. Alpha and angiotensin receptor tone in the near-term sheep fetus. Proc Soc Exp Biol Med 158: 166-169, 1978.
47. Reid DL, Davidson SR, Phernetton TM, and Rankin JH. Adenosine causes a biphasic response in the ovine fetal placental vasculature. J Dev Physiol 13: 237-240, 1990.
48. Reilly FD and Russel PT. Neurohistichemical evidence supporting an absence of adrenergic and cholinergic innervation in the human placenta and umbilical cord. Anat Rec 188: 277-286, 1977.
49. Reviriego J, Alonso MJ, Ibañez C, and Marin J. Action of adenosine and characterization of adenosine receptors in human placental vasculature. Gen Pharmacol 21: 227-233, 1990.
50. Rosenfeld CR, Cox BE, Magness RR, and Shaul PW. Ontogeny of angiotensin II vascular smooth muscle receptors in ovine fetal aorta and placental and uterine arteries. Am J Obstet Gynecol 168: 1562-1569, 1993.
51. 3 receptors expressed in Chinese hamster ovary cells all mediated the phosphorylation of extracellular-regulated kinase. Mol Pharmacol 58: 477-482, 2000.
52. Sebastiao AM and Ribeiro JA. Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 21: 341-346, 2000.
53. Spicuzza L, Bonfiglio C, and Polosa R. Research applications and implications of adenosine in diseased airways. Trends Pharmacol Sci 24: 409-413, 2003.
54. 7 nucleotide receptors in the smooth muscles of human umbilical cord and chorionic blood vessels. Placenta 24: 17-26, 2003.
55. Walsh SW. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 152: 335-340, 1985.
56. Westfall DP, Todorov LD, and Mihaylova-Todorova ST. ATP as a cotransmitter in sympathetic nerves and its inactivation by releasable enzymes. J Pharmacol Exp Ther 303: 439-444, 2002.